<DOC>
	<DOCNO>NCT02363504</DOCNO>
	<brief_summary>The cause Alzheimer 's disease , common form dementia , remain unknown . Neuropathological study suggest small area brainstem , locus coeruleus , might site onset disease . This area sole source noradrenalin brain , neurotransmitter involve arousal , also cognitive function . Animal pharmacological study hint towards important role area memory functioning . However , study hamper limited spatial resolution , make hard clearly localize locus coeruleus brain . New development brain image allow visualize brain stunning precision . Furthermore , non-invasive new stimulation method , transcutaneous vagus nerve stimulation , believe excite locus coeruleus thereby influence neuronal network memory functioning . There three aim project : 1 . To investigate functional interaction locus coeruleus brain area , particular medial temporal lobe area , memory process ( encode , consolidation retrieval ) change development Alzheimer 's disease . 2 . To investigate association noradrenaline , memory performance brain functioning . The investigator aim investigate acute noradrenalin level change different memory process whether beneficial performance . Furthermore , investigator investigate whether interaction noradrenalin , memory performance brain functioning different healthy old individual ( n =35 ) patient prodromal Alzheimer 's disease ( n =35 ) . 3 . To investigate underlying neural network change transcutaneous vagus nerve stimulation . The investigator focus difference functional connectivity locus coeruleus medial temporal lobe area healthy old individual prodromal Alzheimer 's disease patient . An experimental condition compare sham condition pseudo-randomized cross-over design .</brief_summary>
	<brief_title>The Locus Coeruleus Memory</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>For patient : diagnosis prodromal Alzheimer 's disease base late research criterion ( clinical assessment memory clinic : presence least memory impairment , memory complaint express patient informant , problem daily life functioning , dementia presence biomarkers Clinical Dementia Rating score 0.5 ( MiniMental State Examination ( MMSE ) ≥ 23 mentally competent ( general , individual MMSE ≥ 18 consider mentally competent ) Age : 60 85 year old 50 % female Righthandedness Average level education Informed consent participation study For healthy old individual : Average neuropsychological test result , accordance normative data , correct age , education gender No substantial memory complaint ( accord participant ) Age : 60 85 year old 50 % female Righthandedness Average level education Informed consent participation study Reduced vision Psychoactive medication use Abuse alcohol drug Cognitive impairment due alcohol/drug abuse abuse substance Past present psychiatric neurological disorder ( major depression , schizophrenia , bipolar disorder , psychotic disorder ( treatment ) , epilepsy , stroke , Parkinson 's disease , multiple sclerosis , brain surgery , brain trauma , electroshock therapy , kidney dialysis , Menière 's disease , brain infection ) Major vascular disorder ( e.g . stroke ) Heart diseases pacemaker Contraindications scan ( e.g . brain surgery , cardiac pacemaker , metal implant , claustrophobia , body tattoo )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Noradrenaline</keyword>
	<keyword>locus coeruleus</keyword>
	<keyword>memory</keyword>
</DOC>